Features of severe acute respiratory syndrome coronavirus 2 co-infected with other common respiratory pathogens in Shanghai City, 2020-2021

Qi QIU; Dechuan KONG; Zheng TENG; Yanqiu ZHOU; Hongyou CHEN; Xi ZHANG; Jian CHEN; Yaxu ZHENG; Xianjin JIANG; Shiying YUAN; Huanyu WU; Hao PAN; Xiaodong SUN.
Chinese Journal of Infectious Diseases ; (12): 249-254, 2023.
Artículo en Zh | WPRIM | ID: wpr-992533

Documentos relacionados

  1. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.
  2. SARS-CoV-2 coinfection with additional respiratory virus does not predict severe disease: a retrospective cohort study.
  3. High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran.
  4. Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: A retrospective study.
  5. The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.
  6. Smell loss associated with SARS-CoV-2 is not clinically different from other viruses: a multicenter cohort study.
  7. Coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus during the COVID-19 pandemic.
  8. Severe pneumonia with co-infection of H5N1 and SARS-CoV-2: a case report.
  9. Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) /Hepatitis B virus (HBV) Co-infected Patients: A case series and review of the literature.
  10. The characteristics of microbiome in the upper respiratory tract of COVID-19 patients.